A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose.

• Status: Recruiting
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

A Study to Assess the Effect of CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose in Obese Male Subjects and Subjects with T2DM.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Carmot Therapeutics, Inc.

Criteria

Inclusion Criteria:

• Part 1: Obese Otherwise Healthy Males

• Part 2: Males or Females with T2D

• Part 1: BMI 30.0-35.0, inclusive

• Part 2: BMI 27.0-45.0, inclusive

• 18-65 years old, inclusive

• Stable body weight for 2 months

Exclusion Criteria:

• Significant medical history

• Uncontrolled hypertension

• History of malignancy